Service Use and Barriers to Mental Health Care Among Adults With Major Depression and Comorbid Substance Dependence
Supplemental Material
863_ds001.pdf (26 KB)
The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.
Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.
×863_ds001.pdf (26 KB)
This research was supported in part by grants DA030460 and DA023186 from the National Institute on Drug Abuse and AA016346 from the National Institute on Alcohol Abuse and Alcoholism.
Dr. Strain has served as a consultant or as a member of the advisory board for Transcept Pharmaceuticals, Inc.; Salix Pharmaceuticals, Inc.; the Oak Group, Inc.; and Shire Pharmaceuticals. Dr. Mojtabai has received consulting fees from Lundbeck Pharmaceuticals. The other authors report no competing interests.